Concepedia

Matthew Kirisits

MK

3

Publications

86

Citations

3

H-Index

2003

Active since

Affiliations

Princeton University(Current)

Matthew Kirisits is an author at Princeton University specializing in drug discovery, medicine, and pharmacology.

Top concepts

MedicineBiochemistryPharmacologyDrug DiscoveryPharmacotherapySmall MoleculesChemical BiologyNatural SciencesMolecular PharmacologyDrug Resistance

Publications per year

2003–2009

3

Publications

3

Identification, Characterization and Initial Hit-to-Lead Optimization of a Series of 4-Arylamino-3-Pyridinecarbonitrile as Protein Kinase C theta (PKCθ) Inhibitors

Derek C. Cole, Magda Asselin, Agnes Brennan et al. · Journal of Medicinal Chemistry · 2008 · 45 citations · Full text

Tcr Signal Transduction, Drug Target, Inflammatory Lung Disease +19

Anthranilate 4H-oxazol-5-ones: novel small molecule antibacterial acyl carrier protein synthase (AcpS) inhibitors

A. Gilbert, Matthew Kirisits, P.L. Toy et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 29 citations · Full text

Anthranilate 4H-oxazol-5-ones, Biochemistry, Natural Sciences +9

Hit to lead studies on (hetero)arylpyrimidines—Agonists of the canonical Wnt-β-catenin cellular messaging system

A. Gilbert, Matthew G. Bursavich, Nippa Alon et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 12 citations

Molecular Pharmacology, Biochemistry, Medicine +5

Rows per page

1–3 of 3